Trial intelligence / Profile preview

Olmesartan Effects on Cerebral Glucose Metabolism

NCT02996916Phase 4Unknown

Sponsor
Kurume University
Start
Dec 2015
Primary completion
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of olmesartan in essential hypertension, sponsored by Kurume University. Status: unknown.

02

Drugs

olmesartan
03

Conditions

essential hypertension

Beyond the preview

Go deeper on NCT02996916.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02996916.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call